The Prevalence of Group B Streptococcus Positive Pregnant Patients in an

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Completed

Clinical Trial Summary

A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients ;

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04059510` - Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)
Completed	`NCT01150123` - Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women	Phase 1
Completed	`NCT02511444` - Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor	N/A
Completed	`NCT00716781` - Management of Infants Born to Group B Streptococcus Positive Mothers.	N/A
Completed	`NCT01982084` - Group B Streptococcus: Attitudes to Immunisation in Pregnancy
Active, not recruiting	`NCT00972894` - Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study	N/A
Terminated	`NCT00823433` - Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood	Phase 0
Completed	`NCT01180023` - Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients	N/A
Completed	`NCT00008853` - Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines	Phase 1